Cambridge, MA-based Genzyme (NASDAQ:[[ticker:GENZ]]) reported data today from its late-stage clinical trial that compared its drug clofarabine (Clolar) in combination with chemotherpy with chemotherapy and placebo. The firm said that patients in clofarabine-chemotherapy treatment combo arm of the study did not live longer than those in the chemotherapy and placebo arm, but the clofarabine group … Continue reading “Genzyme Cancer Treatment Doubles Remission Rate”
Category: Boston
Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News
IT companies dominated this week’s deals news in New England. Here are some highlights. —Online videogame maker Quick Hit raised $2.5 million in equity financing, according to an SEC filing. The Foxborough, MA-based startup, which has a deal with the National Football League to used official team names, logos, and uniforms for its football role-playing … Continue reading “Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News”
Amylin, Alkermes Shares Crash on Surprise FDA Smackdown
Investors are fuming today about the surprise rejection of the once-weekly diabetes drug developed by San Diego-based Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]), drug giant Eli Lilly, and Waltham, MA-based Alkermes (NASDAQ: [[ticker:ALKS]]). Amylin has the most at stake, and is taking the biggest hit today after news broke about the FDA’s refusal to approval exenatide once-weekly … Continue reading “Amylin, Alkermes Shares Crash on Surprise FDA Smackdown”
Cubist Prices $400M Notes Offering
Cubist Pharmaceuticals (NASDAQ:[[ticker:CBST]]), a Lexington, MA-based provider of acute care drugs such as the antibiotic daptomycin (Cubicin), said in a press release on Tuesday night that it has priced a $400 million convertible notes offering. The notes bear an annual interest rate of 2.5 percent and mature on November 1, 2017, and underwriters of the … Continue reading “Cubist Prices $400M Notes Offering”
Study Shows Startup Executive Pay on the Mend
A study of private information technology and life sciences companies shows that tech executive pay is recovering from a dismal 2009. And it provides the public a rare glimpse at how much executives at startups are paid; that’s information privately held firms don’t have to divulge to the SEC, as public companies do. The CompStudy—completed … Continue reading “Study Shows Startup Executive Pay on the Mend”
The Challenge of Understanding Biotech: Sifting Through the Fog and Jargon
I recently enjoyed reading two books on the mortgage meltdown, “The Big Short” by Michael Lewis and Gregory Zuckerman’s “The Greatest Trade Ever.” They each provided a detailed post-mortem on the implosion of the housing bubble. What fascinated me most about their accounts was how virtually everyone on Wall Street, with a few notable exceptions, … Continue reading “The Challenge of Understanding Biotech: Sifting Through the Fog and Jargon”
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis
One of the interesting new ideas in the treatment of autoimmune disease is approaching a critical turning point at San Diego-based CalciMedica. This little company, so close to the ocean you can smell it from the CEO’s office window, is based in part on some intriguing science that got its start at the Immune Disease … Continue reading “CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis”
Turning “Black Silicon” Into Gold: SiOnyx Closes $12.5M from Bay Area and Seattle Firms, Goes After Image Sensor Market
Quick, name a semiconductor company in the Boston area that’s been getting lots of venture financing lately. OK, well, you already read the headline, so that one doesn’t count. My point is, there haven’t been too many of those—until today. SiOnyx is the Beverly, MA-based semiconductor materials company that is working on commercializing so-called “black … Continue reading “Turning “Black Silicon” Into Gold: SiOnyx Closes $12.5M from Bay Area and Seattle Firms, Goes After Image Sensor Market”
Sionyx Receives $12,500,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d0d639f-9abb-412c-903d-a4eff9242d4a&Preview=1 Date 10/20/2010 Company Name Sionyx Mailing Address 100 Cummings Center Beverly, MA 01915 Company Description SiOnyx is excited to be building a team of industry leading scientists and engineers focused on revolutionizing the field of photonics. Website http://www.sionyxinc.com Transaction Type Venture Equity Transaction Amount $12,500,000 Transaction Round Series B Proceeds Purposes … Continue reading “Sionyx Receives $12,500,000 Series B Funding”
Anexon Garners $7,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4446dfa3-7cc5-4779-a55d-ae8eb1e1e8cf&Preview=1 Date 10/20/2010 Company Name Anexon Mailing Address Undisclosed Cambridge, MA 02142 Company Description The company develops therapeutics for cardiovascular disease. Website Undisclosed Transaction Type Venture Equity Transaction Amount $7,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filings. M&A Terms Venture Investor Undisclosed
Signpost Obtains New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=95e8e67c-7739-4792-b0ed-e065e4d35956&Preview=1 Date 10/20/2010 Company Name Signpost Mailing Address 61 Garfield Street Cambridge, MA 02138 Company Description We make it easy (and free!) for anyone to post, rate and discover great deals: everything from the weekend-only sample sale and the too-good-to-be-true happy hour, to those hidden finds you only hear about when you’re … Continue reading “Signpost Obtains New Funding”
Goby Technologies Secures $2,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a63155f5-3c61-420c-8e7c-79d502eb8320&Preview=1 Date 10/20/2010 Company Name Goby Technologies Mailing Address 201 South Street Boston, MA 02111 Company Description Goby is a search engine focused on exploring fun things to do with your free time, from taking a unique vacation to creating this weekend’s adventure. Website http://www.goby.com Transaction Type Venture Equity Transaction Amount $2,500,000 … Continue reading “Goby Technologies Secures $2,500,000 New Financing Round”
Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval
Bad news out tonight for followers of San Diego-based Amylin Pharmaceuticals, drug giant Eli Lilly, and Waltham, MA-based Alkermes. The new diabetes drug that all three companies have been counting on as a future revenue driver—the once-weekly injectable version of exenatide (Bydureon)—failed to win clearance from the FDA as a new treatment available for sale … Continue reading “Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval”
1366 Technologies Gets $20M Round to Move Solar Tech into Production
1366 Technologies has the cash to advance toward production of technology that could reduce the cost of solar energy. The Lexington, MA-based firm said today it has brought in $20 million in Series B funding, including investments from Korea-based Hanwha Chemical and the European cleantech investor Ventizz Capital Fund. Those new investors joined previous backers … Continue reading “1366 Technologies Gets $20M Round to Move Solar Tech into Production”
Clovr, With New Seed Funding, Looks to Bridge Gaps Between Banks, Advertisers, “Loyalty 2.0”
What do you get when you mix a digital media and marketing entrepreneur with a banking and real estate executive? Answer: Clovr Media, a Boston company that’s officially launching today with $1.5 million in seed funding from Kepha Partners and CommonAngels. Founded by Tom Burgess, the former CEO of Third Screen Media, and Doug Spear, … Continue reading “Clovr, With New Seed Funding, Looks to Bridge Gaps Between Banks, Advertisers, “Loyalty 2.0””
Siluria, Based on MIT Research, Raises $13.3M For Cleaner, Cheaper Plastics
Siluria Technologies, the San Francisco startup developing a low-emissions technique for making the world’s most widely used commodity chemical in plastics, has raised its first big venture round to pursue an idea that has eluded the petrochemical industry for decades. The company, built on technology from Angela Belcher’s materials science lab at MIT, is announcing … Continue reading “Siluria, Based on MIT Research, Raises $13.3M For Cleaner, Cheaper Plastics”
Where Bras Meet Software: Zyrra Raises Money From Jess McLear, Jean Hammond, & Local Angels For Its Bra Industry “Revolution”
Derek Ohly is known as the “bra guy,” both around the office at MassChallenge, the startup accelerator and entrepreneur competition, and throughout the Boston-area investor community, he says. “I didn’t expect to end up in the world of bras, and here I am,” says Ohly, a graduate of Babson College’s MBA program (a likely story). … Continue reading “Where Bras Meet Software: Zyrra Raises Money From Jess McLear, Jean Hammond, & Local Angels For Its Bra Industry “Revolution””
1366 Technologies Receives $20,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b084b96a-aa89-4c0f-93e6-6d0dce5caf4e&Preview=1 Date 10/19/2010 Company Name 1366 Technologies Mailing Address 45 Hartwell Avenue North Lexington, MA 02421 Company Description 1366 Technologies is making silicon solar cells competitive with coal. Our goal is to build on the success of multi-crystalline solar cells and manufacturing capacity to accelerate the transition to solar. Our products and … Continue reading “1366 Technologies Receives $20,000,000 Series B Round”
Clovr Media Garners $1,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ca5d9789-78a6-4969-9ae9-966ddffc0960&Preview=1 Date 10/19/2010 Company Name Clovr Media Mailing Address 225 Franklin St., 26th Floor Boston, MA 02110 Company Description Card Linked Offers (CLOs) are the next generation of digital advertising. A seamless savings experience for consumers, CLOs offer a leap forward for Financial Institutions’ customer loyalty programs and a completely new form … Continue reading “Clovr Media Garners $1,500,000 New Financing Round”
AutoVirt Obtains $3,793,396 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8cb98632-0946-4b9a-9486-c2b19f8a6ced&Preview=1 Date 10/19/2010 Company Name AutoVirt Mailing Address 12 Murphy Drive Nashua, NH 03062 Company Description AutoVirt’s mission is to increase IT productivity by replacing manual labor with automation and virtualization. Virtualization separates the purpose and benefit of a service from its physical implementation and is often the key to greater automation. … Continue reading “AutoVirt Obtains $3,793,396 New Round”
Ray Ozzie to Step Down as Microsoft Chief Software Architect
Microsoft’s chief software architect, Ray Ozzie, will be stepping down from the position after an undefined transitional period, according to Microsoft chief executive Steve Ballmer. Ballmer made the announcement via an e-mail sent out to Microsoft employees today, adding that he had no plans to fill Ozzie’s vacated position. “The CSA role was unique and … Continue reading “Ray Ozzie to Step Down as Microsoft Chief Software Architect”
‘Anything That’s $1B is Good,’ and Other Gems From the Media Lab’s 25th Bash
I spent a good part of Friday at the MIT Media Laboratory, which was packed to the rafters with faculty, alums, and other guests celebrating the pioneering institution’s 25th anniversary. Below are some quick impressions from the morning’s activities and an afternoon chat with Google CEO Eric Schmidt conducted by public radio host John Hockenberry. … Continue reading “‘Anything That’s $1B is Good,’ and Other Gems From the Media Lab’s 25th Bash”
Memento Gets $2M Debt Deal, New CEO
Memento, a Burlington, MA-based developer of software to detect financial fraud, has pulled in a $2 million round of debt financing, according to an SEC filing. In November 2008, the firm raised $10 million in a fourth round of financing from .406 Ventures, Bain Capital Ventures, and Rock Maple Ventures. Last week, Memento announced that … Continue reading “Memento Gets $2M Debt Deal, New CEO”
Shape Up The Nation Wants People to Let Their Friends Help Them Lose Weight
It’s not often that companies offer a reporter his choice of an orange, clementine, banana, or energy bar when he arrives to do an interview. But on a recent visit to the Providence, RI, headquarters of Shape Up The Nation, which dishes out wellness programs on its social networking platform, the staffers were eager to … Continue reading “Shape Up The Nation Wants People to Let Their Friends Help Them Lose Weight”
Abvio vs. FitnessKeeper: The Running App Founder Smackdown
If you’re a runner, walker, or cyclist, there’s a lot of great mobile technology these days to help you track your activity and stay motivated. On Friday I reviewed two apps in particular: RunKeeper from Boston-based FitnessKeeper, and Runmeter from San Francisco-based Abvio. I talked about my personal experiences using the apps, which both work … Continue reading “Abvio vs. FitnessKeeper: The Running App Founder Smackdown”
Dicerna, Actifio Headline Top 10 Third Quarter VC Deals in Massachusetts
[Corrected, 9:50 am. See below] The third quarter of 2010 has been in the books for a couple weeks. Time to look back at the top 10 venture capital financings for Boston-area companies from the past three months (July-September). The roundup comes courtesy of the MoneyTree Report, which is prepared each quarter by PricewaterhouseCoopers and … Continue reading “Dicerna, Actifio Headline Top 10 Third Quarter VC Deals in Massachusetts”
HighRoads Lands $600,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66755eab-e432-48f9-9bbf-07cbcbcdb7bc&Preview=1 Date 10/18/2010 Company Name HighRoads Mailing Address 150 Presidential Way Woburn, MA 01801 Company Description IE-Engine Inc. is the leading developer of Human Resource Cost Management (HRCM) software. The Company’s Web-based applications enable HR decision makers at Global 1000 organizations to make better strategic decisions, reduce costs and increase the quality … Continue reading “HighRoads Lands $600,000 New Funding Round”
Zorap Obtains $850,750 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9626a90d-bf94-4a15-a510-9d23a1ae89a0&Preview=1 Date 10/18/2010 Company Name Zorap Mailing Address 35 Fieldstone Lane Falmouth, ME 04105 Company Description Zorap is the first real-time communication service that allows groups of people to collaboratively experience and enjoy libraries of rich media content in personalized rooms, on fan pages, and on websites.. Website http://www.zorap.com Transaction Type Venture … Continue reading “Zorap Obtains $850,750 New Round”
Twitter Plea Helps Baydin Get Seed Money from Angel Investor Dave McClure; Startup Moving to the Valley Next Month
So an entrepreneur helps out a prominent angel investor when the latter needs a ride, and gets a seed investment as a result. It sounds like something you might see in a movie. But it’s a reality for Baydin, an e-mail technology startup out of Boston (but soon to be based in the San Francisco … Continue reading “Twitter Plea Helps Baydin Get Seed Money from Angel Investor Dave McClure; Startup Moving to the Valley Next Month”
MIT Launching Follow Up to Landmark Made in America Study
With the loss of U.S. manufacturing jobs an ever-present political and economic issue, MIT is kicking off a global manufacturing study, Xconomy has learned. The effort apparently follows up on the school’s famous Made in America report from the late 1980s, which examined the declining state of American industrial productivity and explored ways to get … Continue reading “MIT Launching Follow Up to Landmark Made in America Study”
10 Takeaways from MassTLC’s UnConference
Overwhelming. Inspiring. Thought-provoking. These are all words that apply to the spectacle that was yesterday’s Mass Technology Leadership Council’s Innovation 2010 “unConference,” held at the World Trade Center Boston and organized by entrepreneur and investor Bill Warner, Matrix Partners’ Antonio Rodriguez, and MassTLC’s Tom Hopcroft. And one more word, ridiculous—that’s what it feels like to … Continue reading “10 Takeaways from MassTLC’s UnConference”
RunKeeper Versus Runmeter on the iPhone: A Newbie Runner’s Review
[Corrected, see p. 2] If there’s one seductive thing about being a startup entrepreneur, it’s that you can utterly neglect exercise without feeling guilty about it. After all, doesn’t building a great company require every moment of wakefulness, every ounce of concentration? I know I’ve got a lot to show for my last three years … Continue reading “RunKeeper Versus Runmeter on the iPhone: A Newbie Runner’s Review”
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News
New England area biotechs made the news this week with FDA approvals, clinical study results, new financings, and partnership news. We also saw a few interesting trend and profile pieces on drugmakers. —Boston-based Gelesis, a biotech working on treating obesity, announced that its technology helped rats reduce their food intake over 18 hours when compared … Continue reading “Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News”
Amylin, Alkermes Eagerly Await FDA Verdict (Again) For Once-Weekly Diabetes Drug
Back in March, it was “pins and needles” time at San Diego-based Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]) and Waltham, MA-based Alkermes (NASDAQ: [[ticker:ALKS]]). Now these two companies are getting that prickly feeling again. Both biotech companies are eagerly awaiting word from the FDA on whether the agency will allow the first once-weekly injectable diabetes drug for … Continue reading “Amylin, Alkermes Eagerly Await FDA Verdict (Again) For Once-Weekly Diabetes Drug”
New Reality for U.S. Venture Capital: Data Shows Startup Deals Are Smaller, More Numerous and More Capital-Efficient
The MoneyTree Report on third-quarter venture funding echoes results that we reported earlier this week, showing $4.8 billion was invested in 780 venture deals nationwide. That was a 7 percent decline in venture capital invested—but a nearly 9 percent increase in the number of deals—compared with the same quarter in 2009, when almost $5.2 billion … Continue reading “New Reality for U.S. Venture Capital: Data Shows Startup Deals Are Smaller, More Numerous and More Capital-Efficient”
DragonWave Acquires Axerra Networks for $9,500,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=73410ef4-3d37-4ca3-9abc-f6c08d51ab57&Preview=1 Date 10/15/2010 Company Name Axerra Networks Mailing Address 411 Waverley Oaks Road Waltham, MA 02452 Company Description Axerra Networks is the leading provider of circuit emulation and service emulation solutions over packet access networks. Axerra’s Pseudo-Wire solutions enable mobile wireless operators, cable operators, competitive service providers, and incumbent carriers to extend … Continue reading “DragonWave Acquires Axerra Networks for $9,500,000”
Helicos Names New CEO
Cambridge, MA-based Helicos BioSciences (NASDAQ:[[ticker:HLCS]]), a developer of genetic analysis technology for molecular diagnostics, said today it has named Ivan Trifunovich as the company’s president and CEO. Trifunovich, who was named the firm’s executive chairman on September 15 and has previously served as its consultant, is a former senior vice president of Third Wave Technologies, … Continue reading “Helicos Names New CEO”
Spark Capital Raises $360M Fund
Score one for New England tech VCs. Boston-based venture firm Spark Capital said today it has raised a new $360 million fund to invest in Web and digital media startups. The news was first reported by the New York Times. Spark Capital focuses on early-stage investments in technology, media, and entertainment companies. Its portfolio includes … Continue reading “Spark Capital Raises $360M Fund”
Where, Peekaboo Mobile Team Up for Coupons
Boston-based startups Where and Peekaboo Mobile said today they have formed a partnership to provide location-based coupons to consumers via mobile phones. Financial terms of the partnership weren’t given, but Peekaboo will use Where’s location-based advertising network to extend its mobile coupon service to a larger sphere of consumers and local merchants. Peekaboo Mobile says … Continue reading “Where, Peekaboo Mobile Team Up for Coupons”
NinePoint Medical Raises $33M A Round to Develop New Diagnostic Devices
Cambridge, MA-based NinePoint Medical said this morning it has raised $33 million in a Series A round of funding from Third Rock Ventures of Boston and Prospect Venture Partners of Palo Alto, CA, and it’s planning to quickly beef up its staff with 25 additional workers over the next year. NinePoint is aiming high with … Continue reading “NinePoint Medical Raises $33M A Round to Develop New Diagnostic Devices”
QuickHit Raises $2.5M More
Foxborough, MA-based Quick Hit, a maker of online football role-playing games, has closed $2.5 million in equity financing, according to a regulatory filing. The investors weren’t disclosed, but the company raised an $8 million Series B round in early 2009 from Valhalla Partners, TriplePoint Capital, and New Enterprise Associates. Xconomy first profiled Quick Hit in … Continue reading “QuickHit Raises $2.5M More”
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer
Pretty much anyone who makes a living in the pharmaceutical and biotech business, and has turned on CNBC in the past decade, knows the name Mike Huckman. He reported on the biggest developments in the cancer drug development field in those years, telling the stories of groundbreaking therapies like Eli Lilly’s Erbitux, Roche’s Avastin, and … Continue reading “Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer”
Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology
Fate Therapeutics, after months of hunting, has found a deep-pocketed partner to take its stem cell technology mainstream, at least for academic and pharmaceutical industry labs. The San Diego-based startup—founded by scientific big shots at Harvard University, Stanford University, The Scripps Research Institute, and the University of Washington—is announcing later today that it has struck … Continue reading “Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology”
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge
Outside of certain circles at MIT, you’d be hard pressed to find someone who is familiar with the biotech startup Galenea. The Cambridge, MA-based firm has been researching drugs for schizophrenia and other neurological disorders for more than five years, yet it has done so with a unique funding strategy that has kept its significant … Continue reading “A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge”
NinePoint Medical Receives $33,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=98133cd0-e6cf-4a05-8f6e-3c4dfdfc9b1a&Preview=1 Date 10/14/2010 Company Name NinePoint Medical Mailing Address 29 Newbury Street Boston, MA 02116 Company Description Provides other healthcare products and services. Website Undisclosed Transaction Type Venture Equity Transaction Amount $33,000,000 Transaction Round Series A Proceeds Purposes The money will be used to develop innovative broad-based medical platforms for pathology devices. … Continue reading “NinePoint Medical Receives $33,000,000 Series A Funding Round”
Memento Lands $2,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83781352-fbe4-4e4e-a10f-9704135ed276&Preview=1 Date 10/14/2010 Company Name Memento Mailing Address 55 Network Dr Burlington, MA 01803 Company Description Memento’s QuickMetrics software can help companies manage risk by preventing internal fraud, monitoring a company’s controls and finding indicators of risk, according to the company. Memento’s software can determine if business applications that are in place … Continue reading “Memento Lands $2,000,000 New Funding Round”
Negroponte on the Media Lab’s 25th: A Salon des Refusés That Could Only Have Happened at MIT
The MIT Media Laboratory, whose 1985 launch created a new intellectual center of gravity for studies of the future of computing while blazing trails in industry-university research partnerships, will mark its 25th anniversary this Friday. MIT is celebrating the occasion with a day of festivities that include an appearance from Google CEO Eric Schmidt and … Continue reading “Negroponte on the Media Lab’s 25th: A Salon des Refusés That Could Only Have Happened at MIT”
Investors Suing Genzyme Over Its Handling of Sanofi’s $18.5B Buyout Bid
Genzyme (NASDAQ:[[ticker:GENZ]]) is fending off multiple shareholders who are suing the Cambridge, MA-based biotech company for rejecting French drug giant Sanofi-Aventis’s $18.5 billion buyout offer, according to court documents filed with the SEC. Bloomberg News reported the lawsuits in a story Tuesday afternoon. The lawsuits call attention to Genzyme’s repeated rejection of Sanofi’s (NYSE:[[ticker:SNY]]) offer … Continue reading “Investors Suing Genzyme Over Its Handling of Sanofi’s $18.5B Buyout Bid”
2010 Women’s Leadership Forum: The Successful You
This leadership conference targeted directly at women will highlight what it takes for women to succeed in top positions. Speakers come from the investing and entrepreneur sides of the tech industry, and also feature women in academia. Come for the networking, too. Registration is here.
Isolating the Elusive Management Gene
They have done it. Finally. Biologists at the National University of Singapore have isolated the Management gene. Now DNA technology will forever change how we think about business—and who runs it. That same rigor that was used to sequence the genome can now tell us who is going to be a good/great manager from the … Continue reading “Isolating the Elusive Management Gene”